Djordjevic B

No ORCID on file · 5 papers in corpus · active 2011-2019

Study types

  • article 1

Condition tags

  • adenomyosis 1
2019
The American journal of surgical pathology ·doi:10.1097/pas.0000000000001095

The current World Health Organization (WHO) classification for endocervical adenocarcinoma (EA) is based on descriptive morphologic characteristics; however, it does not fully reflect our current knowledge of the diverse pathogenesis of cer…

2018
Oncogene ·doi:10.1038/s41388-018-0377-y

Estrogenic hormone replacement therapy increases the risk of developing ovarian cancer, and estrogen promotes tumour initiation and growth in mouse models of this disease. GREB1 (Growth regulation by estrogen in breast cancer 1) is an ESR1 …

article 2016
American journal of clinical pathology ·doi:10.1093/ajcp/aqw021

BACKGROUND: Distinguishing myometrial invasion from adenomyosis involvement is important for staging of endometrial endometrioid adenocarcinoma. We aimed to compare CD10, which has limited value in this scenario, with interferon-induced tra…

2013
The American journal of surgical pathology ·doi:10.1097/pas.0b013e318299f2ab

The purpose of this study was to examine predictors of lymph node (LN) metastases or extrauterine disease (ED) in low-grade (FIGO grade 1 or 2) endometrioid carcinoma (LGEC) in a multi-institutional setting. For LGEC with and without LN met…

2011
TheScientificWorldJournal ·doi:10.1100/tsw.2011.112

The last decade witnessed an explosion of interest in cancer stem cells (CSCs). The realization of epithelial ovarian cancer (EOC) as a CSC-related disease has the potential to change approaches in the treatment of this devastating disease …